Anita H Corbett Selected Research

Oculopharyngeal Muscular Dystrophy

1/2019	Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle.
1/2018	Post-transcriptional regulation of Pabpn1 by the RNA binding protein HuR.
10/2017	Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing.
1/2017	Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.
10/2015	An Antibody to Detect Alanine-Expanded PABPN1: A New Tool to Study Oculopharyngeal Muscular Dystrophy.
10/2013	Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle.
3/2010	Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anita H Corbett Research Topics

Disease

11	Intellectual Disability (Idiocy) 01/2022 - 07/2011
7	Oculopharyngeal Muscular Dystrophy 01/2019 - 03/2010
4	Pontocerebellar Hypoplasia 01/2021 - 01/2017
3	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2017 - 01/2014
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021 - 01/2018
2	Neoplasms (Cancer) 01/2018 - 07/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 11/2005
2	Late Onset Disorders 01/2017 - 10/2015
1	Carcinogenesis 01/2022
1	Facies 01/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	Rare Diseases (Rare Disease) 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Muscular Dystrophies (Muscular Dystrophy) 10/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Infections 01/2017
1	Clostridium Infections 01/2017
1	Ulcerative Colitis 01/2017
1	Brain Diseases (Brain Disorder) 07/2011
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 11/2005

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2005
8	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 07/2011
5	Exosome Multienzyme Ribonuclease ComplexIBA 01/2021 - 01/2017
5	polyadenosineIBA 01/2021 - 07/2011
3	Alanine (L-Alanine)FDA Link 01/2019 - 10/2015
3	Carrier Proteins (Binding Protein)IBA 01/2019 - 07/2011
3	polyalanineIBA 01/2017 - 03/2010
3	Messenger RNA (mRNA)IBA 01/2016 - 07/2011
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	AgarIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Poly(A)-Binding Protein IIIBA 01/2017
1	CholesterolIBA 11/2005

Therapy/Procedure

3	Therapeutics 01/2017 - 01/2014
1	Fecal Microbiota Transplantation 01/2017